Patents by Inventor Charles O'Clair

Charles O'Clair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230033406
    Abstract: Trailer mounted portable solar power supplies disclosed can include lights and a backup generator. A solar array with solar panels can be connected to a 360 degree rotatable turntable mounted on a trailer frame enabling the capture of sunlight from all directions. A rotatable telescoping mast with mounted lights can be mounted to the trailer frame. Solar power supply systems can be configured with or without batteries. The AC voltage output can provide electricity for vehicles, homes, buildings, electric vehicles, etc. Portable solar power systems can implement multiple solar arrays to capture more sunlight and generate more electricity. The solar arrays and solar panels are foldable allowing the power system to be retracted for transport. The solar panels can also include sensors to control the positioning of the panels and turn the lights on and off by an onboard computer or wirelessly.
    Type: Application
    Filed: July 28, 2021
    Publication date: February 2, 2023
    Inventor: Charles O. Sayles
  • Patent number: 11566023
    Abstract: Compositions and methods for the treatment of tuberculosis, as well as other mycobacterial and gram positive bacterial infections are disclosed. These compositions contain a highly potent and selective oxazolidinone encapsulated with high efficiency to maximize dosing potential of low toxicity drugs, and are stable in the presence of plasma. The compositions are long circulating and retain their encapsulated drug while in the circulation following intravenous dosing to allow for efficient accumulation at the site of the bacterial or mycobacterial infection. The high doses that can be achieved when combined with the long circulating properties and highly stable retention of the drug allow for a reduced frequency of administration when compared to daily or twice daily administrations of other drugs typically utilized to treat these infections.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: January 31, 2023
    Assignee: Akagera Medicines, Inc.
    Inventors: Daryl C. Drummond, Suresh K. Tipparaju, Charles O. Noble, Alexander Koshkaryev, Dmitri B. Kirpotin
  • Patent number: 11555033
    Abstract: Compositions and methods for the treatment of tuberculosis, as well as other mycobacterial and gram positive bacterial infections are disclosed. These compositions contain a highly potent and selective oxazolidinone encapsulated with high efficiency to maximize dosing potential of low toxicity drugs, and are stable in the presence of plasma. The compositions are long circulating and retain their encapsulated drug while in the circulation following intravenous dosing to allow for efficient accumulation at the site of the bacterial or mycobacterial infection. The high doses that can be achieved when combined with the long circulating properties and highly stable retention of the drug allow for a reduced frequency of administration when compared to daily or twice daily administrations of other drugs typically utilized to treat these infections.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: January 17, 2023
    Assignee: Akagera Medicines, Inc.
    Inventors: Daryl C. Drummond, Suresh K. Tipparaju, Charles O. Noble, Alexander Koshkaryev, Dmitri B. Kirpotin
  • Patent number: 11547709
    Abstract: The present disclosure relates to methods of treating a coenzyme A reduction, elevation, sequestration, toxicity, or redistribution (CASTOR) disease such as, for example, defects in fatty acid oxidation enzymes, methylmalonic acidemia, glutaric acidemia, propionic academia, and HMG-CoA lyase, via small molecule modulators of CoA levels. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: December 26, 2018
    Date of Patent: January 10, 2023
    Assignees: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC., COA THERAPEUTICS, INC.
    Inventors: Suzanne Jackowski, Charles O. Rock, Richard E. Lee, Lalit Kumar Sharma, Mi Kyung Yun, Chitra Subramanian, Rajendra P. Tangallapally, Anne V. Edwards, Robert Zamboni, T. Jagadeeswar Reddy, Jiuyu Liu
  • Publication number: 20220411607
    Abstract: The presently claimed invention relates to aramid pulp comprising a plurality of fibrils having a coating of polyalkyleneimine disposed thereon. The presently claimed invention further relates to a method of coating the aramid pulp with polyalkyleneimine. The presently claimed invention also relates to a rubber composition comprising the coated aramid pulp and rubber as well as to a method for preparing the rubber composition.
    Type: Application
    Filed: January 5, 2021
    Publication date: December 29, 2022
    Inventors: Charles O. Kerobo, John Andrew Randolph, Dennis Frederick Berry, Padma P. Varanasi
  • Patent number: 11511948
    Abstract: A method, electromagnetic switch, controller and program product, when energizing an electromagnetic coil to urge a selected shoe into a diverting path downstream of the electromagnetic switch, reverse current flow during at least a portion of the time that the electromagnetic coil is energized to recover energy from the electromagnetic coil.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: November 29, 2022
    Assignee: LAFAYETTE ENGINEERING, INC.
    Inventors: Robert Bruce Robbins, Timothy Lee Johnson, II, Michael Mckenna, Charles O. Burdine, II, Daniel Blake Robbins
  • Publication number: 20220339875
    Abstract: Techniques for flexible, on-site additive manufacturing of components or portions thereof for transport structures are disclosed. An automated assembly system for a transport structure may include a plurality of automated constructors to assemble the transport structure. In one aspect, the assembly system may span the full vertically integrated production process, from powder production to recycling. At least some of the automated constructors are able to move in an automated fashion between the station under the guidance of a control system. A first of the automated constructors may include a 3-D printer to print at least a portion of a component and to transfer the component to a second one of the automated constructors for installation during the assembly of the transport structure. The automated constructors may also be adapted to perform a variety of different tasks utilizing sensors for enabling machine-learning.
    Type: Application
    Filed: May 13, 2022
    Publication date: October 27, 2022
    Inventors: Kevin Robert CZINGER, Broc William TenHouten, David Charles O'Connell, Jon Paul Gunner, John Russell Bucknell, Alex James Hamade, David Brian TenHouten
  • Patent number: 11436145
    Abstract: A computer directs activity within a computer storage subsystem. The computer identifies a computer operating environment including a computer, and a storage subsystem connected to a group of storage devices. The compute receives metadata representing current and historic performance metrics of said computer operating environment. The computer identifies a first device associated with a first behavior profile governed by a power law distribution, and a second device associated with a second behavior profile governed by a normal distribution. The computer trains Machine Learning (ML) models based on the behavior profiles. The computer establishes Device Performance Rules based on the ML models. The computer forecasts time-based storage system requirements based, at least in part on the Device Performance Rules. The computer prefetches data to a cache component based, at least in part on said forecasted system requirements, in accordance with a time reference available to said computer.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: September 6, 2022
    Assignee: KYNDRYL, INC.
    Inventors: Anil Kumar Narigapalli, Laxmikantha Sai Nanduru, Clea Zolotow, Gavin Charles O'Reilly, Venkateswarlu Basyam
  • Publication number: 20220274975
    Abstract: Compositions and methods for the treatment of tuberculosis, as well as other mycobacterial and gram positive bacterial infections are disclosed. These compositions contain a highly potent and selective oxazolidinone encapsulated with high efficiency to maximize dosing potential of low toxicity drugs, and are stable in the presence of plasma. The compositions are long circulating and retain their encapsulated drug while in the circulation following intravenous dosing to allow for efficient accumulation at the site of the bacterial or mycobacterial infection. The high doses that can be achieved when combined with the long circulating properties and highly stable retention of the drug allow for a reduced frequency of administration when compared to daily or twice daily administrations of other drugs typically utilized to treat these infections.
    Type: Application
    Filed: May 6, 2022
    Publication date: September 1, 2022
    Applicant: Akagera Medicines, Inc.
    Inventors: Daryl C. Drummond, Suresh K. Tipparaju, Charles O. Noble, Alexander Koshkaryev, Dmitri B. Kirpotin
  • Publication number: 20220220082
    Abstract: Emmacin-related substituted dihydropyrimidine compounds demonstrate potency at low concentrations and inhibit Methicillin-resistant S. aureus growth.
    Type: Application
    Filed: January 13, 2022
    Publication date: July 14, 2022
    Inventor: Matthew Charles O'Reilly
  • Publication number: 20220185796
    Abstract: The present disclosure relates to chemical compounds that modulate pantothenate kinase (PanK) activity for the treatment of metabolic disorders (such as diabetes mellitus type II), neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: March 26, 2020
    Publication date: June 16, 2022
    Inventors: Ragendra P. Tangallapally, Richard E. Lee, Anne V. Edwards, Charles O. Rock, Suzanne Jackowski, Mi Kyung Yun, Chitra Subramanian
  • Patent number: 11358337
    Abstract: Techniques for flexible, on-site additive manufacturing of components or portions thereof for transport structures are disclosed. An automated assembly system for a transport structure may include a plurality of automated constructors to assemble the transport structure. In one aspect, the assembly system may span the full vertically integrated production process, from powder production to recycling. At least some of the automated constructors are able to move in an automated fashion between the station under the guidance of a control system. A first of the automated constructors may include a 3-D printer to print at least a portion of a component and to transfer the component to a second one of the automated constructors for installation during the assembly of the transport structure. The automated constructors may also be adapted to perform a variety of different tasks utilizing sensors for enabling machine-learning.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: June 14, 2022
    Assignee: DIVERGENT TECHNOLOGIES, INC.
    Inventors: Kevin Robert Czinger, Broc William TenHouten, David Charles O'Connell, Jon Paul Gunner, John Russell Bucknell, Alex James Hamade, David Brian TenHouten
  • Publication number: 20220130505
    Abstract: Methods, systems, and computer program products for pharmacy substitutions obtain claims data associated with a claim for a prescription associated with a patient; determine, based on the claims data, a universal identifier for the prescription; obtain drug diagnosis data associated with known diagnoses for universal identifiers associated with prescriptions; determine, based on the universal identifier and the drug diagnosis data, a likely diagnosis associated with the prescription; determine, based on the claims data, a cost associated with the likely diagnosis; determine, for the likely diagnosis, using a machine learning model trained based on a training dataset, a potential alternative prescription to the prescription; update, based on user input, the training dataset to include the likely diagnosis associated with the alternative prescription; and train the machine learning model based on the updated training dataset.
    Type: Application
    Filed: October 26, 2021
    Publication date: April 28, 2022
    Inventors: Eric Brannon Molitor, Thomas William Light, Sean Charles O'Brien
  • Patent number: 11307940
    Abstract: A method, system and computer program product for data backup based on a workload behavior includes a first computer identifying, using machine learning tools, data associated with frequently accessed files on the first computer by a workload being processed by a second computer. The first computer processes the identified data associated with the frequently accessed files to generate a list of frequently accessed files by the workload, and compares the list of frequently accessed files to backup policy rules active on the first computer. Based on the comparison, the first computer identifies a mismatch between the list of frequently accessed files and the backup policy rules, and specifies a new backup rule to update the backup policy rules for each identified mismatch between the list of frequently accessed files and the backup policy rules.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: April 19, 2022
    Assignee: Kyndryl, Inc.
    Inventors: Ana Maria Bezerra Maimoni, Gavin Charles O'Reilly, Clea Anne Zolotow, Marci Devorah Formato, Jack Louis Cherkas
  • Patent number: 11294616
    Abstract: The current disclosure relates to a system and method for secured screen sharing. A specially configured screen sharing server of the system may facilitate screen sharing between two independent and remote devices. The system may be configured to access state information from a primary client device. The system may then determine if any of the elements of the application state primary client interface correspond to sensitive information. The system may then mask the primary client interface to create a replica client interface by masking any elements of the application state that correspond to sensitive information. The system may then cause the replica client device to display the replica client interface by transmitting the application state to the replica client interface.
    Type: Grant
    Filed: November 4, 2020
    Date of Patent: April 5, 2022
    Assignee: BLUEOWL, LLC
    Inventors: Charles O. Schwabacher, Hans Oksendahl
  • Publication number: 20220088145
    Abstract: Provided herein are methods and compositions for treating and preventing inflammatory bowel disease.
    Type: Application
    Filed: February 7, 2020
    Publication date: March 24, 2022
    Applicant: THE UAB RESEARCH FOUNDATION
    Inventors: Charles O. Elson, Wayne Duck, Qing Zhao, Katie Alexander
  • Patent number: 11259459
    Abstract: An agricultural product delivery applicator for delivering particulate product to a field. The applicator includes a supply compartment to hold the product and a pneumatic conveying system. The system includes an airflow source to provide an airflow, and a delivery line operably connected to the airflow source and to the supply compartment. The delivery line includes a supply line and a plurality of distribution lines. The system further includes a distributor coupling the supply line with the plurality of distribution lines, a motor disposed on the distribution lines side of the distributor, a shaft assembly rotatable by the motor, and a bearing supporting the shaft assembly on the supply line side of the distributor. The applicator further includes a metering system operably connected between the supply compartment and the pneumatic conveying system. The metering system meters product with the airflow to result in a mixed flow of airflow and product.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: March 1, 2022
    Assignee: CNH Industrial America LLC
    Inventors: Rex LeRoy Ruppert, Nicholas R. Pederson, Charles O'Connell, Jeffrey Scot Martin, John Paul Honermann
  • Patent number: 11244101
    Abstract: Systems and Methods of the current disclosure may provide customized webpages. A client device of the system may retrieve a profile corresponding to a user. The client device may further receive a deck including a set of packs, with each pack including a set of cards. As defined herein, a deck corresponds to a workflow (i.e., a series of webpages), while each pack includes context specific user-interface elements which make up a webpage. Further, a card may correspond to one or more elements of the webpage. The client device renders and displays webpages locally by selecting elements to be displayed on the webpage based on a details corresponding to a user of the client device. In other words, the client device creates webpages by selecting one or more cards for each pack of the deck based on details indicated in the profile.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: February 8, 2022
    Assignee: BLUEOWL, LLC
    Inventors: Hans Oksendahl, Charles O. Schwabacher
  • Publication number: 20220037103
    Abstract: A method, electromagnetic switch, controller and program product, when energizing an electromagnetic coil to urge a selected shoe into a diverting path downstream of the electromagnetic switch, reverse current flow during at least a portion of the time that the electromagnetic coil is energized to recover energy from the electromagnetic coil.
    Type: Application
    Filed: July 31, 2020
    Publication date: February 3, 2022
    Inventors: Robert Bruce Robbins, Timothy Lee Johnson, II, Michael Mckenna, Charles O. Burdine, II, Daniel Blake Robbins
  • Publication number: 20210403463
    Abstract: Compositions and methods for the treatment of tuberculosis, as well as other mycobacterial and gram positive bacterial infections are disclosed. These compositions contain a highly potent and selective oxazolidinone encapsulated with high efficiency to maximize dosing potential of low toxicity drugs, and are stable in the presence of plasma. The compositions are long circulating and retain their encapsulated drug while in the circulation following intravenous dosing to allow for efficient accumulation at the site of the bacterial or mycobacterial infection. The high doses that can be achieved when combined with the long circulating properties and highly stable retention of the drug allow for a reduced frequency of administration when compared to daily or twice daily administrations of other drugs typically utilized to treat these infections.
    Type: Application
    Filed: June 18, 2021
    Publication date: December 30, 2021
    Inventors: Daryl C. Drummond, Suresh K. Tipparaju, Charles O. Noble, Alexander Koshkaryev, Dmitri B. Kirpotin